Treatment of ascites, hyponatremia and hepatorenal syndrome in liver cirrhosis;Therapie von aszites, hyponatriämie und hepatorenalem syndrom bei der leberzirrhose

Therapeutische Umschau

Volumn 66, Issue 11, 2009, Pages 747-751

  Ackermann, Daniel ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; LOOP DIURETIC AGENT; POTASSIUM SPARING DIURETIC AGENT; VASOCONSTRICTOR AGENT; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST;

ASCITES; EXTRACELLULAR SPACE; GLOMERULUS FILTRATION RATE; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HUMAN; HYPONATREMIA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; NEUROHYPOPHYSIS; PARACENTESIS; PATHOGENESIS; REVIEW; SODIUM RETENTION; VASOPRESSIN RELEASE; WATER DEPRIVATION; WATER RETENTION;

ASCITES; DIURETICS; GLOMERULAR FILTRATION RATE; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HUMANS; HYPONATREMIA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PARACENTESIS;

EID: 70350686610     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.66.11.747     Document Type: Review

References (17)

1. Bernardi, M., F. Trevisani, and G. Gasbarrini, The renin-angiotensin- aldosterone system in liver disease., in Cardiovascular Complications of Liver Disease, A. Bonzon and L. Blendis, Editors. 1990, CRC Press Inc.: Boca Raton. p. 29-62.
2. Better, O.S. and R.W. Schrier, Disturbed volume homeostasis in patients with cirrhosis of the liver. Kidney Int, 1983. 23(2): p. 303-311
3. Ackermann, D., et al., Inhibition of 11beta-hydroxysteroid dehydrogenase by bile acids in rats with cirrhosis. Hepatology, 1999. 30(3): p. 623-629
4. Quattropani, C., et al., Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis. J Clin Invest, 2001. 108(9): p. 1299-1305 (Pubitemid 33107757)
5. Ackermann, D., et al., Sodium retention and ascites formation in a cholestatic mice model: role of al dosterone and mineralocorticoid receptor? Hepatology, 2007. 46(1): p. 173-179
6. Perez-Ayuso, R.M., et al., Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system. Gastroenterology, 1983. 84(5 Pt 1): p. 961-968
7. Gines, P., et al., Hyponatremia in cirrhosis: from pathogenesis to treatment. Hepatology, 1998. 28(3): p. 851-864
8. Haussinger, D., Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology, 2006. 43(6): p. 1187-1190
9. Arroyo, V., et al., Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology, 1996. 23(1): p. 164-176
10. Moore, K.P., et al., The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology, 2003. 38(1): p. 258-266
11. Gines, P., et al., Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology, 1988. 94(6): p. 1493-1502
12. Gines, A., et al., Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology, 1996. 111(4): p. 1002-1010
13. Runyon, B.A., Care of patients with ascites. N Engl J Med, 1994. 330(5): p. 337-342
14. Gerbes, A.L., et al., Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial. Gastroenterology, 2003. 124(4): p. 933-939
15. Wong, F., et al., A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial. Hepatology, 2003. 37(1): p. 182-191 (Pubitemid 36042159)
16. Gines, P., et al., Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial. Hepatology, 2008. 48(1): p. 204-213
17. Ortega, R., et al., Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology, 2002. 36(4 Pt 1): p. 941-948